# Celontin

NDC: 0071-0525
Generic name: methsuximide
Labeler / Manufacturer: Parke-Davis Div of Pfizer Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 19570208

FDA application: NDA010596

## Active ingredients

- METHSUXIMIDE: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0071-0525"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0071-0525
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=64a6ee88-c6b1-4e13-8208-b6772ef65a74